Follicular Lymphoma International Prognostic Index (FLIPI)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
flipi score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–1
  • Intermediate Risk2–2
  • High Risk3–5
Direct Clinical Answer

The Follicular Lymphoma International Prognostic Index (FLIPI) calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include age over 60. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates overall survival in patients with follicular lymphoma based on 5 adverse prognostic factors to stratify patients into risk groups for treatment planning.

Clinical Indication

The Follicular Lymphoma International Prognostic Index (FLIPI) is indicated for bedside clinical practice to support Estimates overall survival in patients with follicular lymphoma based on 5 adverse prognostic factors to stratify patients into risk groups for treatment planning.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

Sum of adverse prognostic factors (1 point each): Age >60 years + >4 nodal sites + Elevated LDH + Hemoglobin <120 g/L + Stage III-IV

Input Parameters

NameTypeRequiredDescription
age_over_60stringYesPatient age greater than 60 years
nodal_sites_over_4stringYesMore than 4 nodal sites involved
ldh_elevatedstringYesSerum LDH level above normal
hemoglobin_below_120stringYesHemoglobin level below 120 g/L (12 g/dL)
stage_3_or_4stringYesAnn Arbor stage III or IV disease

Score Interpretation & Guidance

RangeStageDescription
0–1Low Risk0-1 adverse factors
2–2Intermediate Risk2 adverse factors
3–5High Risk3-5 adverse factors

Evidence-Based References (EBM)

  • Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004 Sep 1;104(5):1258-65.
  • van de Schans SA, Steyerberg EW, Nijziel MR, Creemers GJ, Janssen-Heijnen ML, van Spronsen DJ. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting. Ann Oncol. 2009 Oct;20(10):1697-702.
  • Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009 Sep 20;27(27):4555-62.

Related calculators